Results of a compassionate-use program using intravenous ondansetron to prevent nausea and vomiting in patients receiving emetogenic cancer chemotherapy.

Berry, W R

Results of a compassionate-use program using intravenous ondansetron to prevent nausea and vomiting in patients receiving emetogenic cancer chemotherapy. [electronic resource] - Seminars in oncology Dec 1992 - 33-7 p. digital

Publication Type: Journal Article

0093-7754


Adolescent
Adult
Aged
Antineoplastic Agents--adverse effects
Child
Female
Humans
Injections, Intravenous
Male
Middle Aged
Nausea--chemically induced
Neoplasms--drug therapy
Ondansetron--administration & dosage
Vomiting--chemically induced